We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.6B
AUM Growth
-$813M
Cap. Flow
-$1.34B
Cap. Flow %
-10.62%
Top 10 Hldgs %
15.55%
Holding
605
New
149
Increased
96
Reduced
113
Closed
185

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$269M
2
GE icon
GE Aerospace
GE
+$170M
3
ADI icon
Analog Devices
ADI
+$142M
4
KEY icon
KeyCorp
KEY
+$122M
5
MSI icon
Motorola Solutions
MSI
+$108M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$213M
2
GGP
GGP Inc.
GGP
+$153M
3
GD icon
General Dynamics
GD
+$143M
4
ZBH icon
Zimmer Biomet
ZBH
+$119M
5
EQIX icon
Equinix
EQIX
+$104M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Industrials 16.34%
3 Healthcare 11.75%
4 Consumer Discretionary 11.52%
5 Financials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZVRA icon
276
Zevra Therapeutics
ZVRA
$702M
$4.02M 0.03%
62,021
– –
BKD icon
277
Brookdale Senior Living
BKD
$3.43B
$3.96M 0.03%
407,684
-166,431
-29% -$1.7M
TTI icon
278
CALL
TETRA Technologies
TTI
$1.27B
$3.95M 0.03%
925,000
– –
OEC icon
279
Orion
OEC
$429M
$3.84M 0.03%
+150,000
New +$3.55M
LINC icon
280
Lincoln Educational Services
LINC
$1.25B
$3.71M 0.03%
1,836,224
+237,352
+15% +$527K
CISN
281
CALL
DELISTED
Cision Ltd. Ordinary Share
CISN
$3.56M 0.03%
300,000
– –
KALA icon
282
KALA BIO
KALA
$14.2M
$3.51M 0.03%
76
+25
+49% +$1.17M
ASND icon
283
Ascendis Pharma A/S
ASND
$16.4B
$3.46M 0.03%
86,500
-23,500
-21% -$854K
JNCE
284
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.34M 0.03%
262,105
– –
SBNY
285
DELISTED
Signature Bank
SBNY
$3.33M 0.03%
+24,268
New +$3.2M
NGNE icon
286
Neurogene
NGNE
$710M
$3.32M 0.03%
14,128
– –
HTT
287
High Templar Tech Ltd
HTT
$385M
$3.31M 0.03%
+263,682
New +$5.08M
PFG icon
288
Principal Financial Group
PFG
$24.7B
$3.24M 0.03%
45,958
+14,301
+45% +$985K
AKAO
289
DELISTED
Achaogen Inc
AKAO
$3.22M 0.03%
+300,000
New +$3.77M
BLUE
290
DELISTED
bluebird bio
BLUE
$3.21M 0.03%
+1,390
New +$2.82M
STRP
291
DELISTED
Straight Path Communications Inc.
STRP
$3.18M 0.03%
17,488
-82,512
-83% -$15M
ATRA icon
292
Atara Biotherapeutics
ATRA
$74.3M
$3.17M 0.03%
6,995
– –
BA icon
293
Boeing
BA
$184B
$3.16M 0.03%
10,721
-7,170
-40% -$1.94M
PETQ
294
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.15M 0.03%
144,034
+46,288
+47% +$1.07M
CTXS
295
DELISTED
Citrix Systems Inc
CTXS
$3.05M 0.02%
+34,663
New +$2.94M
MULE
296
DELISTED
MuleSoft, Inc.
MULE
$3.05M 0.02%
+131,118
New +$2.97M
FSTX
297
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.05M 0.02%
56,671
-35,297
-38% -$2.1M
ZEN
298
DELISTED
ZENDESK INC
ZEN
$3.04M 0.02%
89,955
-219,785
-71% -$7.19M
ORCL icon
299
Oracle
ORCL
$413B
$3M 0.02%
+63,465
New +$3.11M
NRCG
300
DELISTED
NRC Group Holdings Corp.
NRCG
$2.94M 0.02%
300,000
+204,251
+213% +$2M
10 11
12
13 14

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q4 2017 Portfolio in Review

As of Q4 2017, Alyeska Investment Group held 605 positions worth $12.6B, down 6.1% from $13.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group withdrew a net $1.34B in Q4 2017, closing 185 positions and reducing 113 holdings. Its most notable exit was Texas Instruments, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in IBM worth $272M.

  • Alyeska Investment Group's largest Q4 2017 buy was IBM: 1,851,994 shares worth $272M.
  • Alyeska Investment Group added most to KeyCorp in Q4 2017, an estimated $122M increase.
  • Alyeska Investment Group's biggest Q4 2017 reduction was Equinix, cutting an estimated $104M.
  • Alyeska Investment Group fully exited Texas Instruments in Q4 2017, selling an estimated $213M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $12.6B portfolio in Q4 2017.
  • Alyeska Investment Group opened 149 new positions and closed 185 in Q4 2017.
  • Alyeska Investment Group's portfolio value fell 6.1% quarter-over-quarter to $12.6B.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.